Sun Pharmaceutical Industries reports marginal fall in Q1 consolidated net profit

03 Aug 2023 Evaluate

Sun Pharmaceutical Industries has reported results for first quarter ended June 30, 2023 (Q1FY24). 

The company has reported 62.38% fall in its net profit at Rs 380.64 crore for the quarter under review as compared to Rs 1011.80 crore for the same quarter in the previous year. Total income of the company decreased by 7.07% at Rs 4629.61 crore for Q1FY24 as compared Rs 4981.87 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 1.86% marginal fall in net profit at Rs 2022.54 crore for the first quarter ended June 30, 2023 as compared to Rs 2060.88 crore for the same quarter in the previous year. However, total income of the company increased by 12.83% at Rs 12145.28 crore for Q1FY24 as compared Rs 10763.90 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1826.10 -11.20 (-0.61%)
09-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.10
Dr. Reddys Lab 1371.60
Cipla 1488.15
Lupin 2251.80
Zydus Lifesciences 1009.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.